Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2015 1
2016 1
2018 1
2019 13
2020 10
2021 7
2022 14
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
An update on VEXAS syndrome.
Al-Hakim A, Savic S. Al-Hakim A, et al. Expert Rev Clin Immunol. 2023 Feb;19(2):203-215. doi: 10.1080/1744666X.2023.2157262. Epub 2022 Dec 26. Expert Rev Clin Immunol. 2023. PMID: 36537591 Free article. Review.
A detailed account of its various clinical manifestations and disease mimics is provided. Current treatment and management options are discussed. EXPERT OPINION: New rare variants in UBA1 and VEXAS-like UBA1 negative cases are reported. ...
A detailed account of its various clinical manifestations and disease mimics is provided. Current treatment and management options ar …
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis.
Dubin C, Del Duca E, Guttman-Yassky E. Dubin C, et al. Expert Rev Clin Immunol. 2021 Aug;17(8):835-852. doi: 10.1080/1744666X.2021.1940962. Epub 2021 Jul 21. Expert Rev Clin Immunol. 2021. PMID: 34106037 Review.
We will also detail novel targeted therapeutics that have recently been or are currently in clinical trials for AD. A literature search was conducted by querying Scopus, Google Scholar, PubMed, and Clinicaltrials.gov up to January 2021 using combinations of the search term …
We will also detail novel targeted therapeutics that have recently been or are currently in clinical trials for AD. A literature sear …
Comorbid allergic rhinitis and asthma: important clinical considerations.
Nappi E, Paoletti G, Malvezzi L, Ferri S, Racca F, Messina MR, Puggioni F, Heffler E, Canonica GW. Nappi E, et al. Expert Rev Clin Immunol. 2022 Jul;18(7):747-758. doi: 10.1080/1744666X.2022.2089654. Epub 2022 Jun 19. Expert Rev Clin Immunol. 2022. PMID: 35695326 Review.
EXPERT OPINION: We believe that there are several unmet needs for our patients, however, there are promising advances forecasted for the future. ...A multidisciplinary approach should characterize the journey of patients with respiratory allergies, with an adequate …
EXPERT OPINION: We believe that there are several unmet needs for our patients, however, there are promising advances forecasted for …
Adherence to medication in children and adolescents with asthma: methods for monitoring and intervention.
Pearce CJ, Fleming L. Pearce CJ, et al. Expert Rev Clin Immunol. 2018 Dec;14(12):1055-1063. doi: 10.1080/1744666X.2018.1532290. Epub 2018 Oct 15. Expert Rev Clin Immunol. 2018. PMID: 30286679 Free article. Review.
Areas covered: Several measurement tools have been developed to assess adherence in adults and children with asthma. The current methods for measuring adherence, both subjective and objective, have several flaws and even the current gold standard, electronic monitor …
Areas covered: Several measurement tools have been developed to assess adherence in adults and children with asthma. The current meth …
Establishing diagnostic strategies for cannabis allergy.
Toscano A, Elst J, van der Poorten ML, Beyens M, Heremans K, Decuyper II, Van Gasse AL, Mertens C, Van Houdt M, Hagendorens MM, Sabato V, Ebo DG. Toscano A, et al. Expert Rev Clin Immunol. 2022 Oct;18(10):1015-1022. doi: 10.1080/1744666X.2022.2108791. Epub 2022 Aug 2. Expert Rev Clin Immunol. 2022. PMID: 35912836 Review.
EXPERT OPINION: At present, the diagnosis of IgE-mediated cannabis allergy is based on a three-step approach that starts with accurate history taking and ends with a confirmation of sensitization to the whole extract and, finally, molecular components. Although much …
EXPERT OPINION: At present, the diagnosis of IgE-mediated cannabis allergy is based on a three-step approach that starts with …
Allergen immunotherapy: progress and future outlook.
Šošić L, Paolucci M, Flory S, Jebbawi F, Kündig TM, Johansen P. Šošić L, et al. Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):745-769. doi: 10.1080/1744666X.2023.2209319. Epub 2023 May 5. Expert Rev Clin Immunol. 2023. PMID: 37122076 Review.
INTRODUCTION: Allergy, the immunological hypersensitivity to innocuous environmental compounds, is a global health problem. ...AREAS COVERED: This review will aim to give an overview of the state-of-the-art allergy management, including the use of new biologi …
INTRODUCTION: Allergy, the immunological hypersensitivity to innocuous environmental compounds, is a global health problem. .. …
Eosinophilic esophagitis: does age matter?
Massironi S, Elvevi A, Panceri R, Mulinacci G, Colella G, Biondi A, Invernizzi P, Danese S, Vespa E. Massironi S, et al. Expert Rev Clin Immunol. 2024 Feb;20(2):211-223. doi: 10.1080/1744666X.2023.2274940. Epub 2024 Jan 21. Expert Rev Clin Immunol. 2024. PMID: 37870118 Review.
AREAS COVERED: A search in PubMed/MEDLINE, EMBASE, and SCOPUS databases was conducted to identify relevant studies published between January 2010 and January 2023 to give an overview of the state-of-the-art of EoE epidemiology, diagnosis, and treatment while focusing on similarit …
AREAS COVERED: A search in PubMed/MEDLINE, EMBASE, and SCOPUS databases was conducted to identify relevant studies published between January …
The clinical implications of the microbiome in the development of allergy diseases.
Koidl L, Untersmayr E. Koidl L, et al. Expert Rev Clin Immunol. 2021 Feb;17(2):115-126. doi: 10.1080/1744666X.2021.1874353. Epub 2021 Jan 19. Expert Rev Clin Immunol. 2021. PMID: 33428498 Review.
Introduction: A substantial number of patients worldwide are affected by allergies. Emerging evidence suggests that the individual microbial composition might contribute to the development of allergies or might even protect from allergic diseases.Areas covered: This …
Introduction: A substantial number of patients worldwide are affected by allergies. Emerging evidence suggests that the individual mi …
Current treatment options and long-term outcomes in patients with eosinophilic esophagitis.
Lucendo AJ, Molina-Infante J. Lucendo AJ, et al. Expert Rev Clin Immunol. 2022 Aug;18(8):859-872. doi: 10.1080/1744666X.2022.2096591. Epub 2022 Jul 4. Expert Rev Clin Immunol. 2022. PMID: 35770955
It also discusses limitations re: available literature and outlines data gaps on adherence to therapy and monitoring disease activity in the long-term. EXPERT OPINION: Evidence indicates that long-term maintenance therapy may decrease the risk of esophageal stricture, food …
It also discusses limitations re: available literature and outlines data gaps on adherence to therapy and monitoring disease activity in the …
Endotype-driven precision medicine in chronic rhinosinusitis.
Lou H, Wang C, Zhang L. Lou H, et al. Expert Rev Clin Immunol. 2019 Nov;15(11):1171-1183. doi: 10.1080/1744666X.2020.1679626. Epub 2019 Oct 22. Expert Rev Clin Immunol. 2019. PMID: 31600458 Review.
For CRS with nasal polyps (CRSwNP), type 2-targeting biologics, such as anti-IgE, anti-IL4Ralpha, and anti-IL5 antibodies, have been explored in clinical trials.Expert opinion: In addition to differences in immunopathogenic mechanisms and responses to medical and surgical …
For CRS with nasal polyps (CRSwNP), type 2-targeting biologics, such as anti-IgE, anti-IL4Ralpha, and anti-IL5 antibodies, have been explore …
56 results